EirGenix Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 138.31 million compared to TWD 336.59 million a year ago. Net loss was TWD 194.06 million compared to net income of TWD 6.42 million a year ago. Basic loss per share from continuing operations was TWD 0.64 compared to basic earnings per share from continuing operations of TWD 0.02 a year ago. Diluted loss per share from continuing operations was TWD 0.64 compared to diluted earnings per share from continuing operations of TWD 0.02 a year ago.
For the six months, sales was TWD 354.64 million compared to TWD 698.14 million a year ago. Net loss was TWD 397.54 million compared to net income of TWD 20.27 million a year ago. Basic loss per share from continuing operations was TWD 1.31 compared to basic earnings per share from continuing operations of TWD 0.07 a year ago. Diluted loss per share from continuing operations was TWD 1.31 compared to diluted earnings per share from continuing operations of TWD 0.07 a year ago.